| Nicole E Mubanga, MD | |
|
3003 W Good Hope Rd, Milwaukee, WI 53209 | |
| (414) 352-3100 | |
| Not Available |
| Full Name | Nicole E Mubanga |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 11 Years |
| Location | 3003 W Good Hope Rd, Milwaukee, Wisconsin |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285976563 | NPI | - | NPPES |
| 1285976563 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 63433-20 (Wisconsin) | Secondary |
| 207Q00000X | Family Medicine | 63433 (Wisconsin) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aurora Advanced Healthcare Inc | 3375625833 | 929 |
News Archive
HemaCare Corporation today announced an agreement with Dendreon Corporation to provide cellular collection services in Los Angeles and Maine for their new autologous cellular immunotherapy, PROVENGE® (sipuleucel-T). This personalized medicine is Dendreon's lead product and is the first autologous cellular immunotherapy specifically designed to engage patients' own immune systems to treat cancer.
GPs prescribing antibiotics often rely on their personal preferences and experience, rather than clinical evidence, says new research launched at the British Pharmaceutical Conference (BPC) in Manchester.
To enhance workflow in today's fast-paced healthcare environment, Toshiba America Medical Systems, Inc. announces the FDA-cleared HDR-08A Imaging System for Kalare, which offers Toshiba's same feature-rich Kalare R&F technology with a new innovative user interface and more advanced image processing.
Mersana Therapeutics, Inc., and the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, which operates as EMD Serono in the United States and Canada, announced today an agreement to collaboratively develop next-generation antibody-drug conjugates (ADCs).
MicroStockProfit.com announces an investment report featuring Spectrum Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
› Verified 4 days ago
| Entity Name | Aurora Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427271378 PECOS PAC ID: 6709794258 Enrollment ID: O20031105000725 |
News Archive
HemaCare Corporation today announced an agreement with Dendreon Corporation to provide cellular collection services in Los Angeles and Maine for their new autologous cellular immunotherapy, PROVENGE® (sipuleucel-T). This personalized medicine is Dendreon's lead product and is the first autologous cellular immunotherapy specifically designed to engage patients' own immune systems to treat cancer.
GPs prescribing antibiotics often rely on their personal preferences and experience, rather than clinical evidence, says new research launched at the British Pharmaceutical Conference (BPC) in Manchester.
To enhance workflow in today's fast-paced healthcare environment, Toshiba America Medical Systems, Inc. announces the FDA-cleared HDR-08A Imaging System for Kalare, which offers Toshiba's same feature-rich Kalare R&F technology with a new innovative user interface and more advanced image processing.
Mersana Therapeutics, Inc., and the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, which operates as EMD Serono in the United States and Canada, announced today an agreement to collaboratively develop next-generation antibody-drug conjugates (ADCs).
MicroStockProfit.com announces an investment report featuring Spectrum Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
› Verified 4 days ago
| Entity Name | Lakeshore Medical Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003861188 PECOS PAC ID: 7719890730 Enrollment ID: O20031106000481 |
News Archive
HemaCare Corporation today announced an agreement with Dendreon Corporation to provide cellular collection services in Los Angeles and Maine for their new autologous cellular immunotherapy, PROVENGE® (sipuleucel-T). This personalized medicine is Dendreon's lead product and is the first autologous cellular immunotherapy specifically designed to engage patients' own immune systems to treat cancer.
GPs prescribing antibiotics often rely on their personal preferences and experience, rather than clinical evidence, says new research launched at the British Pharmaceutical Conference (BPC) in Manchester.
To enhance workflow in today's fast-paced healthcare environment, Toshiba America Medical Systems, Inc. announces the FDA-cleared HDR-08A Imaging System for Kalare, which offers Toshiba's same feature-rich Kalare R&F technology with a new innovative user interface and more advanced image processing.
Mersana Therapeutics, Inc., and the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, which operates as EMD Serono in the United States and Canada, announced today an agreement to collaboratively develop next-generation antibody-drug conjugates (ADCs).
MicroStockProfit.com announces an investment report featuring Spectrum Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
› Verified 4 days ago
| Entity Name | Kenosha Community Health Center, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265435960 PECOS PAC ID: 0941195168 Enrollment ID: O20040217000840 |
News Archive
HemaCare Corporation today announced an agreement with Dendreon Corporation to provide cellular collection services in Los Angeles and Maine for their new autologous cellular immunotherapy, PROVENGE® (sipuleucel-T). This personalized medicine is Dendreon's lead product and is the first autologous cellular immunotherapy specifically designed to engage patients' own immune systems to treat cancer.
GPs prescribing antibiotics often rely on their personal preferences and experience, rather than clinical evidence, says new research launched at the British Pharmaceutical Conference (BPC) in Manchester.
To enhance workflow in today's fast-paced healthcare environment, Toshiba America Medical Systems, Inc. announces the FDA-cleared HDR-08A Imaging System for Kalare, which offers Toshiba's same feature-rich Kalare R&F technology with a new innovative user interface and more advanced image processing.
Mersana Therapeutics, Inc., and the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, which operates as EMD Serono in the United States and Canada, announced today an agreement to collaboratively develop next-generation antibody-drug conjugates (ADCs).
MicroStockProfit.com announces an investment report featuring Spectrum Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
› Verified 4 days ago
| Entity Name | Outreach Community Health Centers Inc |
|---|---|
| Entity Type | Part A Provider - Federally Qualified Health Center (fqhc) |
| Entity Identifiers | NPI Number: 1932357126 PECOS PAC ID: 1355247735 Enrollment ID: O20040223000414 |
News Archive
HemaCare Corporation today announced an agreement with Dendreon Corporation to provide cellular collection services in Los Angeles and Maine for their new autologous cellular immunotherapy, PROVENGE® (sipuleucel-T). This personalized medicine is Dendreon's lead product and is the first autologous cellular immunotherapy specifically designed to engage patients' own immune systems to treat cancer.
GPs prescribing antibiotics often rely on their personal preferences and experience, rather than clinical evidence, says new research launched at the British Pharmaceutical Conference (BPC) in Manchester.
To enhance workflow in today's fast-paced healthcare environment, Toshiba America Medical Systems, Inc. announces the FDA-cleared HDR-08A Imaging System for Kalare, which offers Toshiba's same feature-rich Kalare R&F technology with a new innovative user interface and more advanced image processing.
Mersana Therapeutics, Inc., and the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, which operates as EMD Serono in the United States and Canada, announced today an agreement to collaboratively develop next-generation antibody-drug conjugates (ADCs).
MicroStockProfit.com announces an investment report featuring Spectrum Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
› Verified 4 days ago
| Entity Name | Milwaukee Health Services, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518005818 PECOS PAC ID: 7416946884 Enrollment ID: O20040511000114 |
News Archive
HemaCare Corporation today announced an agreement with Dendreon Corporation to provide cellular collection services in Los Angeles and Maine for their new autologous cellular immunotherapy, PROVENGE® (sipuleucel-T). This personalized medicine is Dendreon's lead product and is the first autologous cellular immunotherapy specifically designed to engage patients' own immune systems to treat cancer.
GPs prescribing antibiotics often rely on their personal preferences and experience, rather than clinical evidence, says new research launched at the British Pharmaceutical Conference (BPC) in Manchester.
To enhance workflow in today's fast-paced healthcare environment, Toshiba America Medical Systems, Inc. announces the FDA-cleared HDR-08A Imaging System for Kalare, which offers Toshiba's same feature-rich Kalare R&F technology with a new innovative user interface and more advanced image processing.
Mersana Therapeutics, Inc., and the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, which operates as EMD Serono in the United States and Canada, announced today an agreement to collaboratively develop next-generation antibody-drug conjugates (ADCs).
MicroStockProfit.com announces an investment report featuring Spectrum Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
› Verified 4 days ago
| Entity Name | Aurora Advanced Healthcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265629133 PECOS PAC ID: 3375625833 Enrollment ID: O20080123000694 |
News Archive
HemaCare Corporation today announced an agreement with Dendreon Corporation to provide cellular collection services in Los Angeles and Maine for their new autologous cellular immunotherapy, PROVENGE® (sipuleucel-T). This personalized medicine is Dendreon's lead product and is the first autologous cellular immunotherapy specifically designed to engage patients' own immune systems to treat cancer.
GPs prescribing antibiotics often rely on their personal preferences and experience, rather than clinical evidence, says new research launched at the British Pharmaceutical Conference (BPC) in Manchester.
To enhance workflow in today's fast-paced healthcare environment, Toshiba America Medical Systems, Inc. announces the FDA-cleared HDR-08A Imaging System for Kalare, which offers Toshiba's same feature-rich Kalare R&F technology with a new innovative user interface and more advanced image processing.
Mersana Therapeutics, Inc., and the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, which operates as EMD Serono in the United States and Canada, announced today an agreement to collaboratively develop next-generation antibody-drug conjugates (ADCs).
MicroStockProfit.com announces an investment report featuring Spectrum Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nicole E Mubanga, MD 3003 W Good Hope Rd, Milwaukee, WI 53209-2042 Ph: (414) 352-3100 | Nicole E Mubanga, MD 3003 W Good Hope Rd, Milwaukee, WI 53209 Ph: (414) 352-3100 |
News Archive
HemaCare Corporation today announced an agreement with Dendreon Corporation to provide cellular collection services in Los Angeles and Maine for their new autologous cellular immunotherapy, PROVENGE® (sipuleucel-T). This personalized medicine is Dendreon's lead product and is the first autologous cellular immunotherapy specifically designed to engage patients' own immune systems to treat cancer.
GPs prescribing antibiotics often rely on their personal preferences and experience, rather than clinical evidence, says new research launched at the British Pharmaceutical Conference (BPC) in Manchester.
To enhance workflow in today's fast-paced healthcare environment, Toshiba America Medical Systems, Inc. announces the FDA-cleared HDR-08A Imaging System for Kalare, which offers Toshiba's same feature-rich Kalare R&F technology with a new innovative user interface and more advanced image processing.
Mersana Therapeutics, Inc., and the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, which operates as EMD Serono in the United States and Canada, announced today an agreement to collaboratively develop next-generation antibody-drug conjugates (ADCs).
MicroStockProfit.com announces an investment report featuring Spectrum Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
› Verified 4 days ago
Dr. Mary Grace Hernandez Lasquety, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2311 N Prospect Ave, Milwaukee, WI 53211 Phone: 414-319-3000 Fax: 414-319-3033 | |
Dr. Rodrigo Itable, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2745 W Layton Ave, Suite 201, Milwaukee, WI 53221 Phone: 414-281-0050 Fax: 414-281-0733 | |
Steven Bondow, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1155 N Mayfair Rd, Plank Road Clinic, Milwaukee, WI 53226 Phone: 414-955-5990 Fax: 414-955-6282 | |
Dr. Sabina Diehr, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1155 N Mayfair Rd, Plank Road Clinic, Milwaukee, WI 53226 Phone: 414-955-5990 Fax: 414-955-6282 | |
Luz Stella Moreno, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 637 W Mitchell St, Milwaukee, WI 53204 Phone: 414-383-8989 | |
Quentin Mattern, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 2320 N Lake Dr, Room 3603, Milwaukee, WI 53211 Phone: 414-270-4932 | |
Jennifer Marie Markowski, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 3003 W Good Hope Rd, Milwaukee, WI 53209 Phone: 414-352-3100 |